Biocad, a Russian biotechnology company, has filed registration documents for Russia’s first original gene therapy drug aimed at treating hemophilia B, a rare hereditary disorder that affects blood ...

According to experts, in 5 years, half of the world’s population will suffer from various allergy symptoms. The prevalence of the disease is increasing due to stress, environmental pollution and the ...

The Russian Ministry of Health has registered the drug Forsedeno (INN denosumab), the first domestic biosimilar of an original targeted drug for the treatment of osteoporosis. Petrovax Pharm is the ...

Specialists from the Peoples’ Friendship University of Russia (RUDN) have begun preclinical trials of a new drug for dementia that can not only relieve symptoms, but also restore impaired cognitive ...

PSK Pharma has registered Respiforb Air, a combination of budesonide and formoterol, for the treatment of bronchial asthma. The drug called Respiforb Air will be produced at the company’s own ...

The National Association of Experts in the Field of Primary Immunodeficiencies shared the results of a study evaluating the effectiveness of subcutaneous immunoglobulin administration in patients with ...

The world’s first vaccine targeting allergy to birch pollen and related allergens—including apple, peach, peanut, and soy—has been developed by the Federal Medical and Biological Agency (FMBA) and is ...

Binnopharm Group, a Russian pharmaceutical company, has submitted 50 applications for trademark registration in Asia and the CIS in 2024. These applications, filed through the World Intellectual ...

The portfolio of the Russian biopharmaceutical company PSK Pharma now features another drug, sugammadex, which is used in anesthesiology and intensive care. The Ministry of Health of the Russian ...

Clinical trials of the first Russian CAR-T drug Utjefra (hemagenleucel), developed by the National Research Institute of Hematology of the Ministry of Health, will be completed at the end of 2025.

The Russian biotech company Biocad has received a registration certificate for spinal muscular atrophy drug nusinersen, according to the data included in the State ...

Инновационные таргетные препараты изменили парадигму лечения: теперь лечат не просто симптомы, а причину заболеваний, которые ...